Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.17 | 0.2 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |